Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies
about
Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic ReviewCognitive remission: a novel objective for the treatment of major depression?Peripheral Inflammatory Parameters in Late-Life Depression: A Systematic ReviewMetabolic profiles revealed synergistically antidepressant effects of lilies and Rhizoma Anemarrhenae in a rat model of depression.Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.Neurobehavioral comorbidities of epilepsy: Role of inflammation.Twelve-week physical exercise does not have a long-lasting effect on kynurenines in plasma of depressed patientsRole of Inflammation in Suicide: From Mechanisms to Treatment.Maternal choline status during pregnancy, but not that of betaine, is related to antenatal mental well-being: The growing up in Singapore toward healthy outcomes cohort.HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.Evidence for existence of thyroid hormone inducible semicarbazide-sensitive amine oxidase (SSAO) in rat heart cytosol.Vitamin B-6 and depressive symptomatology, over time, in older Latino adults.Maternal protein restriction during gestation and lactation in the rat results in increased brain levels of kynurenine and kynurenic acid in their adult offspring.The role of neuroinflammation and neurovascular dysfunction in major depressive disorder.An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.Endocrine Crosstalk Between Skeletal Muscle and the BrainPlasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjectsAdiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression
P2860
Q26749017-6DC295E0-96CA-432F-9555-0695F20CD643Q26775386-F35DAFD2-165C-4638-AE3E-50DF306531BCQ28079484-2436E4CE-4F91-426D-A8B3-287012C97D0DQ36232273-74708728-9DD5-495B-B55F-1AA4C9C6DA4EQ37648213-8E1CF1D3-4321-4D2C-B0AB-CBBD3B59E9E4Q38694557-DF79D0DD-4BF1-4FDE-B749-9360025FFD93Q38837505-38C6E9AF-B296-4F6D-B536-798B9C907960Q38885617-73BA794B-450C-4671-9F2C-BDFF71C7083FQ40215668-813D3932-7C0C-43D9-96D0-12042E037181Q40449984-5BBFC8E2-5ED3-4CF5-8242-523E4B76ACDCQ41570461-762D91C1-5929-4AC8-A437-13B4740CD4D7Q47547247-7FE9D02C-68F5-4A46-B78E-F8F858EB2429Q47902256-6282AFC5-C370-43CE-9308-7898D0794A04Q55163955-4A601D68-F960-4DB8-9FE4-5F9312FE57E4Q55381445-30BEFCB0-5277-4EFF-B5C7-92C36D815A05Q58705798-6DB132F3-91CF-442D-AFA1-7176492E10ECQ58772220-883F764D-5490-4A6B-A365-BFA6E9437E30Q58774463-E93ADCB6-B4F0-4E0D-B422-85365F106C89
P2860
Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 May 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Kynurenine pathway dysfunction ...... from animal and human studies
@en
Kynurenine pathway dysfunction ...... from animal and human studies.
@nl
type
label
Kynurenine pathway dysfunction ...... from animal and human studies
@en
Kynurenine pathway dysfunction ...... from animal and human studies.
@nl
prefLabel
Kynurenine pathway dysfunction ...... from animal and human studies
@en
Kynurenine pathway dysfunction ...... from animal and human studies.
@nl
P2093
P2860
P1476
Kynurenine pathway dysfunction ...... from animal and human studies
@en
P2093
André F Carvalho
Gislaine Z Réus
João Quevedo
Karen Jansen
Stephanie Titus
Vilma Gabbay
P2860
P304
P356
10.1016/J.JPSYCHIRES.2015.05.007
P577
2015-05-19T00:00:00Z